A Study to Evaluate KYN-5356 in Adults With Cognitive Impairment Associated With Schizophrenia
Conditions
Cognitive Impairment Associated With Schizophrenia (CIAS)
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Woodland International Research Group, Little Rock, Arkansas, United States
Synapse Clinical Trials, Cerritos, California, United States
Synergy Research Center, Lemon Grove, California, United States
Cenexel CNS, Los Alamitos, California, United States
NeuroBehavioral Hospitals of the Palm Beaches - South, Boynton Beach, Florida, United States
Cenexel RCA, Hollywood, Florida, United States
Segal Trials, Miami Lakes, Florida, United States
Cenexel ACMR, Atlanta, Georgia, United States
Cenexel iResearch Atlanta, Decatur, Georgia, United States
Uptown Research Institute, Chicago, Illinois, United States
Cenexel CBH, Gaithersburg, Maryland, United States
Arch Clinical Trials, St Louis, Missouri, United States
Cenexel HRI, Marlton, New Jersey, United States
Neuro-Behavioral Clinical Research, North Canton, Ohio, United States
Community Clinical Research, Austin, Texas, United States
Contact: Study coordinator (Principal Investigator) · david.brown@communityclinical.com · 512-597-6704